Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares

Zisa, D., Zhang-Sun, J., Christos, P. J., & Kirou, K. A. (2024). Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares. Lupus, 33(9), 938–947. https://doi.org/10.1177/09612033241260283

Authors:

Diane Zisa

Jeffrey Zhang-Sun

Paul J Christos

Kyriakos A Kirou

Affiliated Authors:

Diane Zisa

Subjects:

Lupus Nephritis (MeSH)

Rituximab (MeSH)

B-Lymphocytes (MeSH)

Antibodies, Monoclonal, Humanized (MeSH)